Cleared Special

K092603 - COBAS INTEGRA GLUCOSE HK GEN 3 ASSAY (FDA 510(k) Clearance)

Dec 2009
Decision
101d
Days
Class 2
Risk

K092603 is an FDA 510(k) clearance for the COBAS INTEGRA GLUCOSE HK GEN 3 ASSAY. This device is classified as a Hexokinase, Glucose (Class II - Special Controls, product code CFR).

Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on December 4, 2009, 101 days after receiving the submission on August 25, 2009.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.

Submission Details

510(k) Number K092603 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 25, 2009
Decision Date December 04, 2009
Days to Decision 101 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CFR — Hexokinase, Glucose
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1345